ERYTHROMYCIN BRAND DEVIATION IN INDIA (***RECOMMENDED ACCORDING TO MCI TO WRITE THE PRESCRIPTION IN GENERIC NAME IN LEGIBLE CAPITAL LETTER WITH PROPER FORMULATION AND DOSAGE).

GENERIC NAME : ERYTHROMYCIN
"BRANDS ARE JUST A NAME NOT THE QUALITY IN CASE OF MEDICINE ".

IF THE DRUG IS PRESCRIBED IN A NEAT MANNER THAT A PHARMACIST CAN EASILY UNDERSTAND AND DELIVER THE DRUG IN APPROPRIATE TO THE PRESCRIPTION 
ADVANTAGES OF GENERIC NAME PRESCRIBING:
1. UNETHICAL MARKETING WOULD BE STOPPED.
2. CORRECT DOSE TO THE PATIENT WOULD BE GIVEN .
3. EXPIRY OF DRUGS WILL BE LESS AND WASTAGE OF DRUGS WILL BE LESS.
4. COST EFFECTIVE.
5. CORRECT TREATMENT WOULD BE PROVIDED RATHER THE UNETHICAL OFFERINGS PRESCRIPTION WRITTEN BY THE CORPORATE SOCIETY.
6.LESS CONFUSION.
7. STRONG RELATIONSHIP BETWEEN DOCTORS-PATIENT-PHARMACIST.
8. GETTING FREE TIME TO GAIN KNOWLEDGE FROM A JOURNAL WITHOUT SPENDING TIME WITH REPRESENTATIVES HEARING THE SAME LOOP EVERY WEAK OR EVERY DAY.
9. IMPROVE PATIENT COMPLIANCE .
10. PRACTICE OF WRITING RATIONAL PRESCRIPTION.
11. STOPPING THE DRUG ABUSE.
12.QUALITY BLAME WOULD BE IN THE HANDS OF PHARMACIST.
13.RECORDS OF THE DRUG WOULD BE KEPT PROPER IN THE PHARMACIST AND SAME AS IN CLINICS AND HOSPITALS NO CONFUSION OCCURS
14.PATIENT CAN BE TRACKED EASILY.
15. VISIT TO THE CONCERNED DOCTOR WILL BE REGULAR AS POSSIBLE.
16. PRICE RANGE IS FIXED WHAT EVER THE BRAND IS PRESCRIBED .
DISADVANTAGES OF GENERIC PRESCRIBING:
1.QUALITY DRUGS MUST BE SELECTED BY THE PHARMACIST IT WILL BE QUALITY .IN CASE OF HAVING A PRESCRIPTION HAVE GIVEN TO THE NON PHARMA PERSON RUINING A SHOP WOULD BE IN DANGER OF QUALITY.
2.DOCTORS WONT GET ANY OFFERS AND UNETHICAL MONEY.
3.NO FREE TRIP AS GIVEN BY MANY PHARMACEUTICAL COMPANY.
4. MANY COMPANY MAY EMERGE BECAUSE OF THIS AND MAY PRODUCE LESS QUALITY PRODUCTS (IF THE DRUG CONTROL DEPARTMENT IS STRONG ENOUGH WE CAN TRUST IT)50:50 RATIO ON THIS POINT.
5. PHARMACIES MAY ADD A BILLING OF DISPENSING FEE ON DISPENSING THE PRESCRIPTION AS THE MARGIN LEVEL WAS DOWN (PRACTICED IN UK,USA,CANADA,EUA).

BRANDS AND FORMULATION
********ONLY FOR REFERENCE PURPOSE NOT FOR MARKETING.**********
 BRAND NAME  FORMULATIONMANUFACTURER PACKAGE MRP AS PER 2020
 ALTHROCIN 500MG TABLET ALEMBIC 10 43.10
 ALTHROCIN 250MG
 TABLET ALEMBIC 10 84
 ALTHROCIN 100MG TABLET ALEMBIC 10 17.41
 ALTHROCIN 125 MG TABLET ALEMBIC 10 23.35
 ALTHROCIN 100MG PED.DROPS ALEMBIC 38.80
 ALTHROCIN 125MG/5ML SYRUP ALEMBIC 10 45.20
 ERYTHROCIN 100MG TABLET PFIZER 1016.55
 ERYTHROCIN 250MG TABLET PFIZER 10 37.67
 ERYTHROCIN 500MG TABLET PFIZER 10 80.70
 ERYTHROCIN ***GRANULES*** PFIZER NIL 17.48
 ERYTHROCIN 125MG/5ML  SUSPENSION PFIZER 1 20.92
 ERYCIN 125MG  TABLET CIPLA 10 16.68
 ERYCIN 250MG TABLET CIPLA 10 56.40
 ERYCIN 500MG TABLET CIPLA 10 42.50
 ERYCIN TOPICAL GEL GEL CIPLA 1 44.76
 ERYCIN 125MG SYRUP CIPLA 1 32
 ETOCIN 250 MG TABLET CADILA 10 600
 ERYSAFE 250MG TABLET USV 10 40
 EMTROCIN 250MG TABLET ABBOTT 10 33.08
 EMTROCIN 125/5ML SUSPENSION ABBOTT 1 24.99
 ERYTHRO 250MG
 TABLET OMEGA PAHRMACEUTICALS 10 54.56
 ERYTHRO 500MG TABLET OMEGA PHARMACEUTICALS 10 99.98
 tablet syrup drops topical and micellaneus
 TAB SYRUP PEDATRIC DROPS NOT FOR INDIA***/NOT RELAVENT FORMULATION


                                                                                                            BY
                                                ANANDA PHARMACY.
                                           TAMILNADU,INDIA

Comments

Popular posts from this blog

CODE OF ETHICS FOR PHARMACIST IN INDIA (ACCORDING TO PCI PHARMACIST ARE ALLOWED ONLY TO DISPENSE THE PRESCRIBED MEDICATION OF AN RATIONAL PRESCRIPTION PRESCRIBED BY THE MEDICAL PRACTITIONER (MBBS,MS,MD,BDS,MDS,ETC...),NOT TO PRESCRIBE BY HIMSELF )

(DOCTOR-PHARMACIST RELATIONSHIP IN INDIA IN 2020) A REAL STORY OF PHARMACIST AND DOCTOR PHONE CONVERSATION IN INDIA.***REALITY NOT A FAKE ONE***